Nanjing Pharmaceutical Group Company Limited Class ASSE: 600713

Indicative Announcement on Stopping Conversion of "NPGC Convertible Bonds" When Implementing Dividend Distribution for 2025

· Issued by Nanjing Pharmaceutical Group Company Limited Class A via Shanghai Stock Exchange
Indicative Announcement on Stopping Conversion of "NPGC Convertible Bonds" When Implementing Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment